Journal of Psychosocial Nursing and Mental Health Services

Clip & Save Drug Chart 

New Drugs & Indications for 2018: The Year in Review

Abstract

A handy source of up-to-date information on current medications for psychiatric illnesses

Table

A handy source of up-to-date information on current medications for psychiatric illnesses

Table

Generic (Brand) NameNew FDA-Approved Indication
FEBRUARY
NEW DRUG! Acetominophen and benzhydrocodone hydrochloride (Apadaz®) tabletsTreatment of acute pain
MAY
NEW DRUG! Lofexidine hydrochloride (Lucemyra®) immediate-release tabletsTreatment of opiate withdrawal
NEW DRUG! Erenumab-aooe (Aimovig®) injectionMigraine prophylaxis
JULY
NEW DRUG! Risperidone (Perseris®) extended-release injectable suspensionSchizophrenia
AUGUST
NEW DRUG! Methylphenidate hydrochloride (Jornay PM®) extended-release capsulesAttention-deficit/hyperactivity disorder
SEPTEMBER
NEW DRUG! Buprenorphine and naloxone (Cassipa®) sublingual filmMaintenance treatment of opioid dependence
NEW DRUG! Fremanezumab-vfrm (Ajovy®) injectionPreventive treatment of migraine
NEW DRUG! Galcanezumab-gnlm (Emgality®) injectionPreventive treatment of migraine
NOVEMBER
NEW DRUG! Sufentanil (Dsuvia) sublingual tabletsManagement of acute pain
Authors

10.3928/02793695-20181121-79

Sign up to receive

Journal E-contents